|
|
CIK cells in the treatment of digestive system tumors |
SUN Jie1 WANG Xing1 WANG Cui-fang1 ZHANG Chun-yang2 |
1.Department of Pathology,Affiliated Central Hospital of Shenyang Medical University,Liaoning Province,Shenyang 110024,China;
2.DepartmentofEmergency,Affiliated CentralHospitalofShenyangMedicalUniversity,Liaoning Province,Shenyang 110024,China |
|
|
Abstract ObjectiveTo investigate the therapeutic effect of cik cells on digestive system tumors.MethodsFrom January 1,2012 to February 25,2014,100 cases of digestive system tumor patients in our hospital were selected as the research objects,according to the differences in treatment measures of digestive system tumor patients were divided into control group,experimental group,50 cases in each group.The control group was treated with palliative treatment,while the experimental group was treated with CIK cells.The difference of treatment results between the two groups were compared.ResultsThe levels of CD3+and CD3+CD8+in the experimental group were significantly higher than those in the control group (P<0.05).There was no significant difference between the two groups in OS and PFS (P>0.05).The quality of life of the experimental group was significantly better than that of the control group(P<0.05).The tumor markers(CA 724,CA199)in the experimental group were significantly lower than those in the control group (P<0.05).There was no significant difference in the level of peritoneal effusion between the two groups (P>0.05).ConclusionPatients with digestive system tumors receiving CIK cell therapy can improve their immunity,living standards and tumor markers,but there is no significant improvement in survival time,peritoneal effusion and other aspects.
|
|
|
|
|
[1] |
罗云秀,罗仁峰,何安兵,等.CIK细胞免疫治疗晚期消化系统恶性肿瘤的临床疗效评价[J].现代肿瘤医学,2016,24(8):1246-1248.
|
[2] |
徐梅.化疗联合CIK细胞治疗恶性肿瘤的相关研究及在卵巢癌临床治疗中的观察[D].苏州大学,2014.
|
[3] |
郑振东,梁雪峰,屈淑贤,等.自体CIK细胞治疗对不同阶段肿瘤患者免疫功能的影响[J].临床肿瘤学杂志,2014,20(6):498-502.
|
[4] |
梁瑞华,翟玉萍,李云仙,等.自体CIK细胞治疗消化系统癌症的疗效分析[J].世界临床医学,2016,10(13):19.
|
[5] |
王津.自体CIK细胞治疗恶性肿瘤患者的不良反应分析及在肾癌术后患者中的应用[D].北京:中国人民解放军总医院,2015.
|
[6] |
李霞,赵稳兴,蔡琳,等.化疗联合CIK免疫疗法治疗晚期消化道肿瘤 86 例观察[J].解放军医药杂志,2014,26(5):38-40,61.
|
[7] |
戴夕超,石亮荣,孙明芬,等.射频消融与细胞因子诱导的杀伤细胞协同抗肿瘤效应的研究[J].中华实验外科杂志,2016,33(6):1552-1556.
|
[8] |
李旺,陈艳媛,魏志璋,等.TLR7激动剂替代IFN-γ诱导CIK细胞杀伤肿瘤的研究[J].中国免疫学杂志,2016,32(8):1157-1159.
|
[9] |
单婵婵,石亮荣,丁美钱,等.肿瘤射频消融裂解物负载的DC-CIK细胞体外抗肿瘤活性实验研究[J].国际肿瘤学杂志,2014,41(6):471-475.
|
[10] |
庞春淼,吕艳,孙雯雯,等.负载干细胞抗原的DC联合CIK细胞对乳腺癌荷瘤鼠肿瘤杀伤研究[J].天津医药,2014,56(6):554-557.
|
[11] |
姚冰清,贾原,郭继强,等.盐酸埃克替尼和细胞因子诱导的杀伤细胞对肺腺癌细胞的体外杀伤作用研究[J].中华肿瘤杂志,2017,39(8):573-578.
|
[12] |
庞冲,张腾月,王长利,等.肿瘤干细胞来源的DC-CIK对同源肿瘤细胞的杀伤作用[J].天津医药,2014,56(10):972-976.
|
[13] |
赵俊峰,曾宝珠,岳俊敏,等.CIK细胞结合中药扶正固本治疗中晚期肾脏肿瘤[J].中国现代医学杂志,2014,24(18):41-44.
|
[14] |
李付贵,陈京,李晓玲,等.肿瘤可溶性抗原联合超抗原致敏的DC诱导CIK对鼻咽癌细胞杀伤作用的研究[J].中国实验诊断学,2015,19(12):1987-1991.
|
[15] |
杨智.CIK细胞联合表达白介素12的溶瘤腺病毒治疗肝癌的疗效及机制研究[D].重庆:第三军医大学,2016.
|
|
|
|